Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. $MJ Marijuana News Message Board

CBD industry to grow to $2 Billion by 2022 Hem

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 3448
(Total Views: 120)
Posted On: 08/14/2018 8:18:09 AM
Avatar
Posted By: mc67
CBD industry to grow to $2 Billion by 2022

Hemp-Derived CBD Products Outpaced Marijuana-Derived CBD Products for First Time

Washington, Aug. 14, 2018 (GLOBE NEWSWIRE) -- WASHINGTON – New Frontier Data, the global authority in data, analytics and business intelligence on the cannabis industry, releases The CBD Report: 2018 Industry Outlook. In this report, New Frontier Data estimates that the U.S. CBD industry grew by nearly 40 percent in 2017, reaching $367 million in sales across hemp-derived and marijuana-derived markets. This marks the first year that sales of hemp-derived CBD products outpaced marijuana-derived CBD products. Surging demand is expected to lift both markets higher and 2018 will be a break-out year for CBD, with the total market expanding to more than $500 million in sales. The CBD industry will grow to $1.2 billion by 2020, and nearly $2 billion by 2022.

The U.S. CBD market is primed for expansive growth across its three primary sectors, hemp-derived CBD, marijuana-derived CBD and pharmaceutical CBD. We have already observed market shifts in 2017 as the hemp-derived CBD sector outpaced marijuana-derived CBD for the first time, and we expect to see continued changes as the pharmaceutical sector officially opens in 2018. We project that by 2022, each of these three sectors will account for approximately one-third of the $1.9 billion total market,

said New Frontier Data CEO Giadha Aguirre de Carcer.

Among the key findings from the report:

The U.S. hemp-derived CBD market is estimated to grow to $646 million in 2022.
The U.S. marijuana-derived CBD market is estimated to grow to $647 million in 2022.
The start of sales of Epidiolex in late 2018 or early 2019 will officially open the pharmaceutical channel; Epidiolex will account for approximately one-third of the total CBD market by 2022, with sales of over $625 million.
In 2017, there were over 25,500 acres of hemp grown across 19 states; 70 percent for CBD, 20 percent for seed and 10 percent for fiber.


https://www.ftmig.com/cannabis-marijuana/cbd-...n-by-2022/


(0)
(0)




$MJ




Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us